Position in SPRY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$66,556,735
-$30,004,406 QoQ
Shares Held
8,288,510
0.0% QoQ
Ownership
8.35%
of shares outstanding
% of Portfolio
1.35%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SPRY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ORBIMED ADVISORS LLC holds $2,871,604,021 across 72 Biotechnology names. SPRY ranks #11 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EWTX |
Edgewise Therapeutics, Inc.
|
15,518,492 | $488,832,498 | |
| 2 | ELVN |
Enliven Therapeutics, Inc.
|
7,959,538 | $312,013,889 | |
| 3 | SION |
Sionna Therapeutics, Inc.
|
3,530,702 | $141,545,843 | |
| 4 | MBX |
MBX Biosciences, Inc.
|
3,637,887 | $108,590,926 | |
| 5 | CRVS |
Corvus Pharmaceuticals, Inc.
|
7,165,006 | $104,824,037 | |
| 6 | ARGX |
Argenx SE
|
136,900 | $99,971,225 | |
| 7 | CMPX |
Compass Therapeutics, Inc.
|
15,219,994 | $80,513,768 | |
| 8 | GPCR |
Structure Therapeutics Inc.
|
1,475,403 | $71,114,424 |
All Filings in SPRY
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $66,556,735 | 8,288,510 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $96,561,141 | 8,288,510 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $83,299,525 | 8,288,510 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $144,634,499 | 8,288,510 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $104,269,455 | 8,288,510 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $87,443,780 | 8,288,510 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $120,183,395 | 8,288,510 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $78,639,948 | 9,240,887 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $94,441,865 | 9,240,887 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $50,640,060 | 9,240,887 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $34,930,552 | 9,240,887 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $58,563,942 | 8,740,887 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $56,903,174 | 8,740,887 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $74,559,766 | 8,740,887 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $46,151,883 | 8,740,887 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $37,061,360 | 8,740,887 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $30,680,513 | 8,740,887 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $58,214,307 | 8,740,887 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $87,234,052 | 8,740,887 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $270,005,999 | 8,740,887 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $381,364,899 | 8,740,887 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $405,052,703 | 8,740,887 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||